HealthFinSMEsabout 4 hours ago
Prolific Machines Raises $50M Series B2
1 min read
San Francisco biotech firm Prolific Machines raised an initial closing of $50M in Series B2 funding led by Atoms & Bits and Nant Capital. The round brings total capital to over $100M for CEO Deniz Kent to scale its optogenetics-enabled biomanufacturing platform.
Level
Hype check
Tap to vote and see what everyone thinks.
